カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の気分安定薬（ムードスタビライザー）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Mood Stabilizers Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO20823）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO20823
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の気分安定薬（ムードスタビライザー）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

気分安定薬（ムードスタビライザー）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の気分安定薬（ムードスタビライザー）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

気分安定薬（ムードスタビライザー）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・カルバマゼピン、ラモトリギン、バルプロ酸、アセナピン

用途別セグメントは次のように区分されます。
・病院薬局、ドラッグストア、その他

世界の気分安定薬（ムードスタビライザー）市場の主要な市場プレーヤーは以下のとおりです。
・Bristol-Myers Squibb、Pfizer、GlaxoSmithKline、Otsuka Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、気分安定薬（ムードスタビライザー）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な気分安定薬（ムードスタビライザー）メーカーの企業概要、2019年～2022年までの気分安定薬（ムードスタビライザー）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な気分安定薬（ムードスタビライザー）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別気分安定薬（ムードスタビライザー）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの気分安定薬（ムードスタビライザー）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での気分安定薬（ムードスタビライザー）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および気分安定薬（ムードスタビライザー）の産業チェーンを掲載しています。
・第13、14、15章では、気分安定薬（ムードスタビライザー）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 気分安定薬（ムードスタビライザー）の概要
- 種類別分析（2017年vs2021年vs2028年）：カルバマゼピン、ラモトリギン、バルプロ酸、アセナピン
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、ドラッグストア、その他
- 世界の気分安定薬（ムードスタビライザー）市場規模・予測
- 世界の気分安定薬（ムードスタビライザー）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bristol-Myers Squibb、Pfizer、GlaxoSmithKline、Otsuka Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：カルバマゼピン、ラモトリギン、バルプロ酸、アセナピン
・用途別分析2017年-2028年：病院薬局、ドラッグストア、その他
・気分安定薬（ムードスタビライザー）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・気分安定薬（ムードスタビライザー）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・気分安定薬（ムードスタビライザー）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・気分安定薬（ムードスタビライザー）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・気分安定薬（ムードスタビライザー）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Mood Stabilizers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Mood Stabilizers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Mood Stabilizers global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Carbamazepine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Mood Stabilizers include Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Otsuka Pharmaceutical, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mood Stabilizers market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Carbamazepine
Lamotrigine
Valproate
Asenapine
Market segment by Application can be divided into
Hospital Pharmacies
Drug Stores
Others
The key market players for global Mood Stabilizers market are listed below:
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Otsuka Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mood Stabilizers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mood Stabilizers, with price, sales, revenue and global market share of Mood Stabilizers from 2019 to 2022.
Chapter 3, the Mood Stabilizers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mood Stabilizers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mood Stabilizers market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mood Stabilizers.
Chapter 13, 14, and 15, to describe Mood Stabilizers sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Mood Stabilizers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mood Stabilizers Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Carbamazepine
1.2.3 Lamotrigine
1.2.4 Valproate
1.2.5 Asenapine
1.3 Market Analysis by Application
1.3.1 Overview: Global Mood Stabilizers Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Others
1.4 Global Mood Stabilizers Market Size & Forecast
1.4.1 Global Mood Stabilizers Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mood Stabilizers Sales in Volume (2017-2028)
1.4.3 Global Mood Stabilizers Price (2017-2028)
1.5 Global Mood Stabilizers Production Capacity Analysis
1.5.1 Global Mood Stabilizers Total Production Capacity (2017-2028)
1.5.2 Global Mood Stabilizers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mood Stabilizers Market Drivers
1.6.2 Mood Stabilizers Market Restraints
1.6.3 Mood Stabilizers Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Mood Stabilizers Product and Services
2.1.4 Bristol-Myers Squibb Mood Stabilizers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Mood Stabilizers Product and Services
2.2.4 Pfizer Mood Stabilizers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Mood Stabilizers Product and Services
2.3.4 GlaxoSmithKline Mood Stabilizers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Otsuka Pharmaceutical
2.4.1 Otsuka Pharmaceutical Details
2.4.2 Otsuka Pharmaceutical Major Business
2.4.3 Otsuka Pharmaceutical Mood Stabilizers Product and Services
2.4.4 Otsuka Pharmaceutical Mood Stabilizers Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mood Stabilizers Breakdown Data by Manufacturer
3.1 Global Mood Stabilizers Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mood Stabilizers Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mood Stabilizers
3.4 Market Concentration Rate
3.4.1 Top 3 Mood Stabilizers Manufacturer Market Share in 2021
3.4.2 Top 6 Mood Stabilizers Manufacturer Market Share in 2021
3.5 Global Mood Stabilizers Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mood Stabilizers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mood Stabilizers Market Size by Region
4.1.1 Global Mood Stabilizers Sales in Volume by Region (2017-2028)
4.1.2 Global Mood Stabilizers Revenue by Region (2017-2028)
4.2 North America Mood Stabilizers Revenue (2017-2028)
4.3 Europe Mood Stabilizers Revenue (2017-2028)
4.4 Asia-Pacific Mood Stabilizers Revenue (2017-2028)
4.5 South America Mood Stabilizers Revenue (2017-2028)
4.6 Middle East and Africa Mood Stabilizers Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mood Stabilizers Sales in Volume by Type (2017-2028)
5.2 Global Mood Stabilizers Revenue by Type (2017-2028)
5.3 Global Mood Stabilizers Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mood Stabilizers Sales in Volume by Application (2017-2028)
6.2 Global Mood Stabilizers Revenue by Application (2017-2028)
6.3 Global Mood Stabilizers Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mood Stabilizers Sales by Type (2017-2028)
7.2 North America Mood Stabilizers Sales by Application (2017-2028)
7.3 North America Mood Stabilizers Market Size by Country
7.3.1 North America Mood Stabilizers Sales in Volume by Country (2017-2028)
7.3.2 North America Mood Stabilizers Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mood Stabilizers Sales by Type (2017-2028)
8.2 Europe Mood Stabilizers Sales by Application (2017-2028)
8.3 Europe Mood Stabilizers Market Size by Country
8.3.1 Europe Mood Stabilizers Sales in Volume by Country (2017-2028)
8.3.2 Europe Mood Stabilizers Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mood Stabilizers Sales by Type (2017-2028)
9.2 Asia-Pacific Mood Stabilizers Sales by Application (2017-2028)
9.3 Asia-Pacific Mood Stabilizers Market Size by Region
9.3.1 Asia-Pacific Mood Stabilizers Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mood Stabilizers Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mood Stabilizers Sales by Type (2017-2028)
10.2 South America Mood Stabilizers Sales by Application (2017-2028)
10.3 South America Mood Stabilizers Market Size by Country
10.3.1 South America Mood Stabilizers Sales in Volume by Country (2017-2028)
10.3.2 South America Mood Stabilizers Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mood Stabilizers Sales by Type (2017-2028)
11.2 Middle East & Africa Mood Stabilizers Sales by Application (2017-2028)
11.3 Middle East & Africa Mood Stabilizers Market Size by Country
11.3.1 Middle East & Africa Mood Stabilizers Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mood Stabilizers Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mood Stabilizers and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mood Stabilizers
12.3 Mood Stabilizers Production Process
12.4 Mood Stabilizers Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mood Stabilizers Typical Distributors
13.3 Mood Stabilizers Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Mood Stabilizers Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Mood Stabilizers Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Mood Stabilizers Product and Services
Table 6. Bristol-Myers Squibb Mood Stabilizers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Mood Stabilizers Product and Services
Table 10. Pfizer Mood Stabilizers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Mood Stabilizers Product and Services
Table 14. GlaxoSmithKline Mood Stabilizers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Otsuka Pharmaceutical Major Business
Table 17. Otsuka Pharmaceutical Mood Stabilizers Product and Services
Table 18. Otsuka Pharmaceutical Mood Stabilizers Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Mood Stabilizers Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Mood Stabilizers Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Mood Stabilizers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Mood Stabilizers Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Mood Stabilizers Production Site of Key Manufacturer
Table 24. Mood Stabilizers New Entrant and Capacity Expansion Plans
Table 25. Mood Stabilizers Mergers & Acquisitions in the Past Five Years
Table 26. Global Mood Stabilizers Sales by Region (2017-2022) & (K Units)
Table 27. Global Mood Stabilizers Sales by Region (2023-2028) & (K Units)
Table 28. Global Mood Stabilizers Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Mood Stabilizers Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Mood Stabilizers Sales by Type (2017-2022) & (K Units)
Table 31. Global Mood Stabilizers Sales by Type (2023-2028) & (K Units)
Table 32. Global Mood Stabilizers Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Mood Stabilizers Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Mood Stabilizers Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Mood Stabilizers Price by Type (2023-2028) & (USD/Unit)
Table 36. Global Mood Stabilizers Sales by Application (2017-2022) & (K Units)
Table 37. Global Mood Stabilizers Sales by Application (2023-2028) & (K Units)
Table 38. Global Mood Stabilizers Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Mood Stabilizers Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Mood Stabilizers Price by Application (2017-2022) & (USD/Unit)
Table 41. Global Mood Stabilizers Price by Application (2023-2028) & (USD/Unit)
Table 42. North America Mood Stabilizers Sales by Country (2017-2022) & (K Units)
Table 43. North America Mood Stabilizers Sales by Country (2023-2028) & (K Units)
Table 44. North America Mood Stabilizers Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Mood Stabilizers Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Mood Stabilizers Sales by Type (2017-2022) & (K Units)
Table 47. North America Mood Stabilizers Sales by Type (2023-2028) & (K Units)
Table 48. North America Mood Stabilizers Sales by Application (2017-2022) & (K Units)
Table 49. North America Mood Stabilizers Sales by Application (2023-2028) & (K Units)
Table 50. Europe Mood Stabilizers Sales by Country (2017-2022) & (K Units)
Table 51. Europe Mood Stabilizers Sales by Country (2023-2028) & (K Units)
Table 52. Europe Mood Stabilizers Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Mood Stabilizers Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Mood Stabilizers Sales by Type (2017-2022) & (K Units)
Table 55. Europe Mood Stabilizers Sales by Type (2023-2028) & (K Units)
Table 56. Europe Mood Stabilizers Sales by Application (2017-2022) & (K Units)
Table 57. Europe Mood Stabilizers Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Mood Stabilizers Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Mood Stabilizers Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Mood Stabilizers Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Mood Stabilizers Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Mood Stabilizers Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Mood Stabilizers Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Mood Stabilizers Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Mood Stabilizers Sales by Application (2023-2028) & (K Units)
Table 66. South America Mood Stabilizers Sales by Country (2017-2022) & (K Units)
Table 67. South America Mood Stabilizers Sales by Country (2023-2028) & (K Units)
Table 68. South America Mood Stabilizers Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Mood Stabilizers Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Mood Stabilizers Sales by Type (2017-2022) & (K Units)
Table 71. South America Mood Stabilizers Sales by Type (2023-2028) & (K Units)
Table 72. South America Mood Stabilizers Sales by Application (2017-2022) & (K Units)
Table 73. South America Mood Stabilizers Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Mood Stabilizers Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Mood Stabilizers Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Mood Stabilizers Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Mood Stabilizers Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Mood Stabilizers Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Mood Stabilizers Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Mood Stabilizers Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Mood Stabilizers Sales by Application (2023-2028) & (K Units)
Table 82. Mood Stabilizers Raw Material
Table 83. Key Manufacturers of Mood Stabilizers Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Mood Stabilizers Typical Distributors
Table 87. Mood Stabilizers Typical Customers
List of Figures
Figure 1. Mood Stabilizers Picture
Figure 2. Global Mood Stabilizers Revenue Market Share by Type in 2021
Figure 3. Carbamazepine
Figure 4. Lamotrigine
Figure 5. Valproate
Figure 6. Asenapine
Figure 7. Global Mood Stabilizers Revenue Market Share by Application in 2021
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Others
Figure 11. Global Mood Stabilizers Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Mood Stabilizers Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Mood Stabilizers Sales (2017-2028) & (K Units)
Figure 14. Global Mood Stabilizers Price (2017-2028) & (USD/Unit)
Figure 15. Global Mood Stabilizers Production Capacity (2017-2028) & (K Units)
Figure 16. Global Mood Stabilizers Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Mood Stabilizers Market Drivers
Figure 18. Mood Stabilizers Market Restraints
Figure 19. Mood Stabilizers Market Trends
Figure 20. Global Mood Stabilizers Sales Market Share by Manufacturer in 2021
Figure 21. Global Mood Stabilizers Revenue Market Share by Manufacturer in 2021
Figure 22. Mood Stabilizers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Mood Stabilizers Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Mood Stabilizers Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Mood Stabilizers Sales Market Share by Region (2017-2028)
Figure 26. Global Mood Stabilizers Revenue Market Share by Region (2017-2028)
Figure 27. North America Mood Stabilizers Revenue (2017-2028) & (USD Million)
Figure 28. Europe Mood Stabilizers Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Mood Stabilizers Revenue (2017-2028) & (USD Million)
Figure 30. South America Mood Stabilizers Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Mood Stabilizers Revenue (2017-2028) & (USD Million)
Figure 32. Global Mood Stabilizers Sales Market Share by Type (2017-2028)
Figure 33. Global Mood Stabilizers Revenue Market Share by Type (2017-2028)
Figure 34. Global Mood Stabilizers Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Mood Stabilizers Sales Market Share by Application (2017-2028)
Figure 36. Global Mood Stabilizers Revenue Market Share by Application (2017-2028)
Figure 37. Global Mood Stabilizers Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Mood Stabilizers Sales Market Share by Type (2017-2028)
Figure 39. North America Mood Stabilizers Sales Market Share by Application (2017-2028)
Figure 40. North America Mood Stabilizers Sales Market Share by Country (2017-2028)
Figure 41. North America Mood Stabilizers Revenue Market Share by Country (2017-2028)
Figure 42. United States Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Mood Stabilizers Sales Market Share by Type (2017-2028)
Figure 46. Europe Mood Stabilizers Sales Market Share by Application (2017-2028)
Figure 47. Europe Mood Stabilizers Sales Market Share by Country (2017-2028)
Figure 48. Europe Mood Stabilizers Revenue Market Share by Country (2017-2028)
Figure 49. Germany Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Mood Stabilizers Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Mood Stabilizers Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Mood Stabilizers Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Mood Stabilizers Revenue Market Share by Region (2017-2028)
Figure 58. China Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Mood Stabilizers Sales Market Share by Type (2017-2028)
Figure 65. South America Mood Stabilizers Sales Market Share by Application (2017-2028)
Figure 66. South America Mood Stabilizers Sales Market Share by Country (2017-2028)
Figure 67. South America Mood Stabilizers Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Mood Stabilizers Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Mood Stabilizers Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Mood Stabilizers Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Mood Stabilizers Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Mood Stabilizers Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Mood Stabilizers in 2021
Figure 79. Manufacturing Process Analysis of Mood Stabilizers
Figure 80. Mood Stabilizers Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のトリス（2-ヒドロキシエチル）イソシアヌレート（THEIC）市場2022年：市場規模予測（～2028年）
  • 世界の医療用銅管（パイプ）市場2022年：市場規模予測（～2028年）
  • 世界のペースメーカー及び植込み型除細動器（ICD）市場2022年：市場規模予測（～2028年）
  • 世界の血栓活性剤（BCA）市場2022年：市場規模予測（～2028年）
  • 世界のマイクロニードル（極細針）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO20823 )"世界の気分安定薬（ムードスタビライザー）市場2022年：市場規模予測（～2028年）" (英文：Global Mood Stabilizers Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。